GoodRx Holdings GDRX Cash Flow Statement (2019-2026)

NASDAQ GDRX
$3.48 -0.05 (-1.42%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

GoodRx Holdings Quarterly Cash Flow Statement

Periods 28 quarters
Latest Jun 2026

GoodRx Holdings reported cash from operations of $80.83M and free cash flow of $66.78M for the quarter ended Jun 2026, up 63.0% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-18.07M-39.91M12.29M-1.42M-41.73M-1.97M-3.29M58.79M-38.49M-25.87M-1.01M6.69M3.96M6.74M11.05M12.84M1.12M5.42M1.17M8.54M
Share-based CompensationStock Comp.
23.77M36.90M30.15M194.50M204.60M29.41M25.50M17.90M32.65M28.78M25.10M26.59M26.38M20.96M19.17M21.41M18.12M17.92M16.51M16.59M
Deferred Taxes
-32.85M46.07M-0.39M0.06M0.20M-0.36M0.04M-63.02M4.99M-7.57M-0.64M-11.27M8.09M11.98M4.07M5.71M
Gains from Investment SecuritiesGains Investment
1.80M1.20M
Cash from OperationsCash from Ops.
48.56M49.81M30.12M51.05M33.73M31.88M32.29M29.87M60.27M15.87M42.59M9.70M86.86M44.74M9.41M49.58M76.02M32.89M11.84M80.83M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
1.05M1.20M1.09M0.98M1.00M0.94M0.93M0.98M
Amortization of Deferred ChargesAmort. Deferred Charges
0.86M0.86M0.86M0.85M0.85M0.85M0.85M0.85M0.84M0.84M0.84M0.83M0.41M0.42M0.43M0.44M0.45M0.45M0.46M0.47M
Depreciation & Amortization (CF)Dep. & Amort.
10.16M10.65M11.37M13.32M13.95M15.53M14.94M16.10M33.02M43.61M15.94M16.96M17.54M19.10M20.91M19.73M21.43M23.15M21.79M22.27M
Change in Working Capital
Change in ReceivablesChange Receivables
11.51M19.57M5.20M-0.84M-1.99M-3.75M-0.70M6.94M-2.23M22.46M1.16M17.00M-30.97M15.13M14.18M28.91M14.71M30.21M-3.02M-50.58M
Change in Account PayablesChange Payables
-0.59M-0.12M-4.44M2.58M-6.15M7.14M-4.74M-6.24M25.49M-2.48M-2.45M-15.56M-5.15M7.35M0.29M3.29M11.05M-10.52M-4.95M-4.93M
Change in Accured ExpensesChange Accured Exp.
7.21M8.69M-17.20M15.11M11.19M-14.37M1.18M17.23M7.65M-4.82M0.92M1.05M17.80M-9.87M-10.56M16.14M36.62M-40.22M1.74M14.32M
Investing Activities
Capital ExpendituresCapex
7.80M8.45M10.68M12.29M13.13M15.14M14.14M14.67M13.45M12.46M20.21M16.96M15.46M16.48M21.73M17.93M16.25M14.59M20.51M14.05M
Acquisitions
14.54M6.98M149.88M30.00M13.44M
Cash from Investing ActivitiesCash from Investing
-27.06M-9.26M-34.40M-163.61M-13.78M1.29M-14.29M-14.96M-13.65M-12.87M-20.61M-17.23M-15.86M-16.64M-51.88M-18.32M-18.00M-31.77M-21.64M-14.41M
Financing Activities
Other financing activitiesOther financing
14.23M5.31M3.68M4.16M1.27M0.05M0.71M0.56M3.12M1.56M2.58M9.19M6.66M0.61M0.00M0.86M0.45M0.10M0.27M
Cash from Financing ActivitiesCash from Financing
-4.18M-11.46M-91.40M-2.33M-21.71M-4.79M-14.09M-13.99M-13.71M-125.61M-160.97M-0.86M-172.13M-3.53M-104.90M-50.93M-65.81M-12.83M-16.30M-6.02M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.33M0.28M1.16M3.78M2.63M7.58M
Additional items
Change in Cash
17.32M29.09M-95.68M-114.89M-1.75M28.38M3.91M0.91M32.92M-122.61M-139.00M-8.39M-101.13M24.57M-147.37M-19.66M-7.79M-11.71M-26.11M60.40M
Free Cash FlowFCF
40.75M41.36M19.44M38.75M20.60M16.74M18.15M15.20M46.82M3.40M22.38M-7.26M71.41M28.26M-12.32M31.66M59.77M18.30M-8.67M66.78M
Net Cash FlowNCF
17.32M29.09M-95.68M-114.89M-1.75M28.38M3.91M0.91M32.92M-122.61M-139.00M-8.39M-101.13M24.57M-147.37M-19.66M-7.79M-11.71M-26.11M60.40M